Peer Review reports
From: ING3 promotes prostate cancer growth by activating the androgen receptor
| Original Submission | ||
|---|---|---|
| 17 Oct 2016 | Submitted | Original manuscript |
| 19 Nov 2016 | Reviewed | Reviewer Report - Zoran Culig |
| 22 Nov 2016 | Reviewed | Reviewer Report - John Isaacs |
| 1 Dec 2016 | Reviewed | Reviewer Report - Charles Massie |
| 28 Feb 2017 | Author responded | Author comments - Arash Nabbi |
| Resubmission - Version 2 | ||
| 28 Feb 2017 | Submitted | Manuscript version 2 |
| 9 Mar 2017 | Author responded | Author comments - Arash Nabbi |
| Resubmission - Version 3 | ||
| 9 Mar 2017 | Submitted | Manuscript version 3 |
| 17 Mar 2017 | Reviewed | Reviewer Report - Charles Massie |
| 1 Apr 2017 | Reviewed | Reviewer Report - Zoran Culig |
| 4 Apr 2017 | Author responded | Author comments - Arash Nabbi |
| Resubmission - Version 4 | ||
| 4 Apr 2017 | Submitted | Manuscript version 4 |
| Publishing | ||
| 7 Apr 2017 | Editorially accepted | |
| 16 May 2017 | Article published | 10.1186/s12916-017-0854-0 |
You can find further information about peer review here.